Suppr超能文献

肺孢子菌和克氏锥虫:命名与模式指定

Pneumocystis and Trypanosoma cruzi: nomenclature and typifications.

作者信息

Redhead Scott A, Cushion Melanie T, Frenkel Jacob K, Stringer James R

机构信息

National Program on Environmental Health-Biodiversity, Agriculture and Agri-Food Canada, Central Experimental Farm, KW Neatby Building, 960 Carling Avenue, Ottawa, Ontario K1A 0C6, Canada.

出版信息

J Eukaryot Microbiol. 2006 Jan-Feb;53(1):2-11. doi: 10.1111/j.1550-7408.2005.00072.x.

Abstract

Published phylogenetic reclassifications of Pneumocystis as a fungus resulted in a nomenclatural shift from the Zoological Code to the International Code of Botanical Nomenclature. The same may be true for all microsporidians and sundry other organisms. This resulted in the invalidation of names and subsequently precipitated changes to the botanical code to accommodate Pneumocystis and microsporidian names. The repercussions following application of the 2005 Vienna Code to Pneumocystis nomenclature are detailed. Validity of the name for the human pathogen, Pneumocystis jirovecii, is re-established from its 1976 publication under the Zoological Code, contrary to interpretation of validity under earlier botanical codes. Pneumocystis jirovecii is lectotypified and epitypified. The rat parasite, Pneumocystis carinii, is neotypified, separating it from Pneumocystis wakefieldiae. The original 1909 description of Trypanosoma cruzi, type species for Schizotrypanum, and causal agent of Chagas' disease, included parts of the life cycle of Pneumocystis. Trypanosoma cruzi is neotypified by the true Trypanosoma elements, thereby completing the nomenclatural separation from Pneumocystis and ensuring that Schizotrypanum is not applicable to Pneumocystis as an earlier name. The neotypes for P. carinii and T. cruzi represent the strains currently being investigated by their two respective genome projects. They were selected in light of their medical importance, physiological characterizations, and absence of lectotypifiable materials. The classification and nomenclature of Pneumocystis is reviewed and guidelines given for the publication of new species.

摘要

已发表的将肺孢子菌重新分类为真菌的系统发育研究导致了命名法从动物学命名法规转向国际植物命名法规。所有微孢子虫和其他各类生物可能也是如此。这导致了一些名称失效,随后促使植物命名法规做出修改以接纳肺孢子菌和微孢子虫的名称。详细阐述了2005年《维也纳法规》应用于肺孢子菌命名法后的影响。人类病原体耶氏肺孢子菌的名称有效性从1976年依据动物学命名法规发表时起得以重新确立,这与早期植物命名法规对有效性的解释相反。耶氏肺孢子菌被选定模式标本和后选模式标本。大鼠寄生虫卡氏肺孢子菌被指定新模式标本,使其与韦氏肺孢子菌区分开来。1909年对克氏锥虫(裂殖锥虫属的模式种,恰加斯病的病原体)的原始描述包含了肺孢子菌的部分生命周期。克氏锥虫由真正的锥虫成分指定新模式标本,从而完成了与肺孢子菌的命名分离,并确保裂殖锥虫作为一个较早的名称不适用于肺孢子菌。卡氏肺孢子菌和克氏锥虫的新模式标本代表了目前其各自两个基因组项目正在研究的菌株。它们是根据其医学重要性、生理学特征以及缺乏可指定模式标本的材料而选定的。对肺孢子菌的分类和命名进行了综述,并给出了新物种发表的指南。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验